| 摘要 |
<p>The invention relates to a formulation of N-[[1-[[2 -(diethylamino) ethyl] amino]-7-methoxy- 9-oxothioxanthen -4-yl] -methyl]formamide, or a pharmaceutically acceptable acid-addition salt thereof, and to the method of use thereof in the treatment of tumors and cancers.</p> |
